無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

関節鏡下手術器具の世界市場:技術・市場シェア・産業予測

Global Arthroscopy Instruments Market-Technologies, Market share and Industry Forecast to 2024

発行 Occams Business Research & Consulting Pvt. Ltd. 商品コード 745707
出版日 ページ情報 英文 240 Pages
納期: お問合せ
価格
本日の銀行送金レート: 1USD=114.61円で換算しております。
Back to Top
関節鏡下手術器具の世界市場:技術・市場シェア・産業予測 Global Arthroscopy Instruments Market-Technologies, Market share and Industry Forecast to 2024
出版日: 2018年11月21日 ページ情報: 英文 240 Pages
概要

当レポートでは、世界の関節鏡下外科手術向け医療器具の市場について分析し、市場の概略や最新動向、主な市場促進・阻害要因、目下の課題と将来の機会、種類別・用途別・エンドユーザー別・地域別の市場動向予測 (過去3年間・今後7年間分)、市場競争の動き、主要企業のプロファイルなどを調査しております。

第1章 イントロダクション

第2章 市場概要

  • 世界の関節鏡下手術器具市場:進化と変遷
  • 市場の定義と範囲
  • 産業構造
  • 規制体制
  • 市場全体の分析
  • 推計分析
  • 戦略分析
    • 投資/導入モデル
    • 全方位的な産業分析
    • ポーターのファイブフォース分析
    • シーソー分析
    • 消費者分析と主な購入基準
  • 市場競争分析
    • 主要戦略・分析
    • 市場シェア分析、主要企業の分析
  • 戦略的提言と主な結論
    • 各地域での市場機会
    • 新規分野での市場機会
    • 急成長市場での投資機会

第3章 市場の決定要因

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の課題

第4章 世界の関節鏡下手術器具市場:種類別

  • 市場の定義と範囲
  • 意思決定支援データベースおよび推計手法
  • 市場間の比較分析
  • 市場機会マトリックス
  • 市場区分
    • 関節鏡
    • 関節鏡インプラント
    • 流体管理システム
    • 電動シェーバー
    • 高周波 (RF) アブレーション装置
    • 可視化システム

第5章 世界の関節鏡下手術器具市場:用途別

  • 市場区分
    • 膝関節向け
    • 肩関節向け
    • その他

第6章 世界の関節鏡下手術器具市場:エンドユーザー別

  • 市場区分
    • 日帰り手術センター (ASC)/開業医向け
    • 病院向け

第7章 競争環境

  • 主な戦略
    • 企業合併・買収 (M&A) の一覧
    • 合弁事業 (JV) の一覧
    • 製品発売の一覧
    • 事業提携の一覧

第8章 地域別分析

  • 意思決定支援データベースおよび推計手法
  • 市場間の比較分析
  • 市場機会マトリックス
  • 地域別の市場分析:市場規模 (金額ベース、通算10年間分)
    • 北米市場 (米国、カナダ)
    • 欧州市場 (英国、フランス、ドイツ、スペインなど)
    • アジア太平洋地域市場 (中国、インド、日本、オーストラリアなど)
    • 他の国々 (RoW:ラテンアメリカ、中東・アフリカ)

第9章 企業プロファイル

  • ARTHREX (米国)
    • 概要
    • 製品ポートフォリオ
    • 戦略展開状況
    • SCOT分析
    • 戦略分析
  • B. BRAUN MELSUNGEN AG (ドイツ)
  • CONMED (米国)
  • DEPUY SYNTHES COMPANIES (米国)
  • GPC MEDICAL (インド)
  • KARL STORZ (ドイツ)
  • MEDICON (ドイツ)
  • MEDTRONIC (米国)
  • オリンパス (日本)
  • RICHARD WOLF GMBH (ドイツ)
  • SKLAR (米国)
  • SMITH & NEPHEW (英国)
  • STRYKER CORPORATION (米国)
  • SYMMETRY SURGICAL (米国)
  • ZIMMER BIOMET (米国)
図表

LIST OF TABLES

  • 1. GLOBAL ARTHROSCOPY INSTRUMENTS MARKET BY PRODUCT 2015-2024 ($ MILLION)
  • 2. GLOBAL ARTHROSCOPE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  • 3. GLOBAL ARTHROSCOPY IMPLANTS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  • 4. GLOBAL FLUID MANAGEMENT SYSTEMS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  • 5. GLOBAL MOTORIZED SHAVERS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  • 6. GLOBAL RF ABLATION SYSTEMS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  • 7. GLOBAL VISUALIZATION SYSTEMS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  • 8. GLOBAL ARTHROSCOPY INSTRUMENTS MARKET BY APPLICATIONS 2015-2024 ($ MILLION)
  • 9. GLOBAL KNEE ARTHROSCOPY MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  • 10. GLOBAL SHOULDER ARTHROSCOPY MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  • 11. GLOBAL OTHER ARTHROSCOPY APPLICATIONS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  • 12. GLOBAL ARTHROSCOPY INSTRUMENTS MARKET BY END USER2015-2024 ($ MILLION)
  • 13. GLOBAL AMBULATORY SURGICAL CENTERS & CLINICS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  • 14. GLOBAL HOSPITALS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  • 15. NORTH AMERICA ARTHROSCOPY INSTRUMENTS MARKET 2015-2024 ($ MILLION)
  • 16. EUROPE ARTHROSCOPY INSTRUMENTS MARKET 2015-2024 ($ MILLION)
  • 17. ASIA PACIFIC ARTHROSCOPY INSTRUMENTS MARKET 2015-2024 ($ MILLION)
  • 18. REST OF THE WORLD ARTHROSCOPY INSTRUMENTS MARKET 2015-2024 ($ MILLION)
  • 19. NORTH AMERICA ARTHROSCOPY INSTRUMENTS MARKET BY PRODUCT 2015-2024 ($ MILLION)
  • 20. EUROPE ARTHROSCOPY INSTRUMENTS MARKET BY PRODUCT 2015-2024 ($ MILLION)
  • 21. ASIA PACIFIC ARTHROSCOPY INSTRUMENTS MARKET BY PRODUCT 2015-2024 ($ MILLION)
  • 22. REST OF THE WORLD ARTHROSCOPY INSTRUMENTS MARKET BY PRODUCT 2015-2024 ($ MILLION)
  • 23. NORTH AMERICA ARTHROSCOPY INSTRUMENTS MARKET BY APPLICATION 2015-2024 ($ MILLION)
  • 24. EUROPE ARTHROSCOPY INSTRUMENTS MARKET BY APPLICATION 2015-2024 ($ MILLION)
  • 25. ASIA PACIFIC ARTHROSCOPY INSTRUMENTS MARKET BY APPLICATION 2015-2024 ($ MILLION)
  • 26. REST OF THE WORLD ARTHROSCOPY INSTRUMENTS MARKET BY APPLICATION 2015-2024 ($ MILLION)
  • 27. NORTH AMERICA ARTHROSCOPY INSTRUMENTS MARKET BY END USER 2015-2024 ($ MILLION)
  • 28. EUROPE ARTHROSCOPY INSTRUMENTS MARKET BY END USER 2015-2024 ($ MILLION)
  • 29. ASIA PACIFIC ARTHROSCOPY INSTRUMENTS MARKET BY END USER 2015-2024 ($ MILLION)
  • 30. REST OF THE WORLD ARTHROSCOPY INSTRUMENTS MARKET BY END USER 2015-2024 ($ MILLION)
  • 31. UNITED STATES ARTHROSCOPY INSTRUMENTS MARKET BY PRODUCT 2015-2024 ($ MILLION)
  • 32. CANADA ARTHROSCOPY INSTRUMENTS MARKET BY PRODUCT 2015-2024 ($ MILLION)
  • 33. UK ARTHROSCOPY INSTRUMENTS MARKET BY PRODUCT 2015-2024 ($ MILLION)
  • 34. FRANCE ARTHROSCOPY INSTRUMENTS MARKET BY PRODUCT 2015-2024 ($ MILLION)
  • 35. GERMANY ARTHROSCOPY INSTRUMENTS MARKET BY PRODUCT 2015-2024 ($ MILLION)
  • 36. SPAIN ARTHROSCOPY INSTRUMENTS MARKET BY PRODUCT 2015-2024 ($ MILLION)
  • 37. ROE ARTHROSCOPY INSTRUMENTS MARKET BY PRODUCT 2015-2024 ($ MILLION)
  • 38. CHINA ARTHROSCOPY INSTRUMENTS MARKET BY PRODUCT 2015-2024 ($ MILLION)
  • 39. INDIA ARTHROSCOPY INSTRUMENTS MARKET BY PRODUCT 2015-2024 ($ MILLION)
  • 40. JAPAN ARTHROSCOPY INSTRUMENTS MARKET BY PRODUCT 2015-2024 ($ MILLION)
  • 41. AUSTRALIA ARTHROSCOPY INSTRUMENTS MARKET BY PRODUCT 2015-2024 ($ MILLION)
  • 42. ROAPAC ARTHROSCOPY INSTRUMENTS MARKET BY PRODUCT 2015-2024 ($ MILLION)
  • 43. LATIN AMERICA ARTHROSCOPY INSTRUMENTS MARKET BY PRODUCT 2015-2024 ($ MILLION)
  • 44. MENA ARTHROSCOPY INSTRUMENTS MARKET BY PRODUCT 2015-2024 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ARTHROSCOPE MARKET 2015-2024 ($ MILLION)
  • 2. GLOBAL ARTHROSCOPY IMPLANTS MARKET 2015-2024 ($ MILLION)
  • 3. GLOBAL FLUID MANAGEMENT SYSTEMS MARKET 2015-2024 ($ MILLION)
  • 4. GLOBAL MOTORIZED SHAVERS MARKET 2015-2024 ($ MILLION)
  • 5. GLOBAL RF ABLATION SYSTEMS MARKET 2015-2024 ($ MILLION)
  • 6. GLOBAL VISUALIZATION SYSTEMS MARKET 2015-2024 ($ MILLION)
  • 7. GLOBAL KNEE ARTHROSCOPY MARKET 2015-2024 ($ MILLION)
  • 8. GLOBAL SHOULDER ARTHROSCOPY MARKET 2015-2024 ($ MILLION)
  • 9. GLOBAL OTHER ARTHROSCOPY APPLICATIONS MARKET 2015-2024 ($ MILLION)
  • 10. GLOBAL AMBULATORY SURGICAL CENTERS & CLINICS MARKET 2015-2024 ($ MILLION)
  • 11. GLOBAL HOSPITALS MARKET 2015-2024 ($ MILLION)
  • 12. UNITED STATES (U.S.) ARTHROSCOPY INSTRUMENTS MARKET 2015-2024 ($ MILLION)
  • 13. CANADA ARTHROSCOPY INSTRUMENTS MARKET 2015-2024 ($ MILLION)
  • 14. UNITED KINGDOM (UK) ARTHROSCOPY INSTRUMENTS MARKET 2015-2024 ($ MILLION)
  • 15. FRANCE ARTHROSCOPY INSTRUMENTS MARKET 2015-2024 ($ MILLION)
  • 16. GERMANY ARTHROSCOPY INSTRUMENTS MARKET 2015-2024 ($ MILLION)
  • 17. SPAIN ARTHROSCOPY INSTRUMENTS MARKET 2015-2024 ($ MILLION)
  • 18. ROE ARTHROSCOPY INSTRUMENTS MARKET 2015-2024 ($ MILLION)
  • 19. INDIA ARTHROSCOPY INSTRUMENTS MARKET 2015-2024 ($ MILLION)
  • 20. CHINA ARTHROSCOPY INSTRUMENTS MARKET 2015-2024 ($ MILLION)
  • 21. JAPAN ARTHROSCOPY INSTRUMENTS MARKET 2015-2024 ($ MILLION)
  • 22. AUSTRALIA ARTHROSCOPY INSTRUMENTS MARKET 2015-2024 ($ MILLION)
  • 23. ROAPAC ARTHROSCOPY INSTRUMENTS MARKET 2015-2024 ($ MILLION)
  • 24. LATIN AMERICA ARTHROSCOPY INSTRUMENTS MARKET 2015-2024 ($ MILLION)
  • 25. MENA ARTHROSCOPY INSTRUMENTS MARKET 2015-2024 ($ MILLION)
目次
Product Code: HME-10971118

Global arthroscopy instruments market is expected to rise with the CAGR of about 6% during the forecast period 2017-2024. High prevalence of musculoskeletal disorders is one of the major factor which contributes to the growth of global arthroscopy instruments market during the forecast period. However, high cost of arthroscopy instruments and reimbursement challenges in the medical device industry are some of the major factors restraining the growth of the global arthroscopy instruments market during the forecast period.

Geographically, the global arthroscopy instruments market report has been segmented in North America, Asia Pacific, Europe and Rest of the World. North America held the largest market revenue share for the arthroscopy instruments market in 2016 and is expected to dominate the market during the forecast period due to presence of a large patient population. However, Asia Pacific is expected to emerge as the fastest growing region in the arthroscopy instruments market during the forecast period due to various factors such as growth in the geriatric population, growth in healthcare expenditure, etc.

The growth in the global arthroscopy instruments market is also influenced by the presence of major players such as Stryker Corporation (United States), Zimmer Biomet (United States), Richard Wolf Gmbh (Germany), Smith & Nephew (United Kingdom), Depuy Synthes Companies (United States), etc. To gain competitive advantage, the major players of global arthroscopy instruments market are adopting various strategies such as mergers & acquisitions, product launch, strategic partnership, collaboration, joint ventures, investment, strategic expansion, funding etc. during the forecast period.

The report on the global arthroscopy instruments market is widely categorized on the basis of its segments such as product, applications and end users. On the basis of product the global arthroscopy instruments market is divided into arthroscope, arthroscopic implants, RF ablation system, visualization system, motorized shavers, and fluid management system.. On the basis of application, the market is divided into shoulder arthroscopy, knee arthroscopy, and other arthroscopy applications. Other arthroscopy applications further includes foot arthroscopy, hip arthroscopy, elbow arthroscopy, ankle arthroscopy, and wrist arthroscopy.. End user segment in arthroscopy instruments are segmented as ambulatory surgical centers & clinics and hospitals. The other application is expected to gain the fastest growth in application segment during the forecast period majorly due to factors such as increasing focus of manufacturers for the development of new instruments to perform hip arthroscopy surgeries, increase in the number of hip arthroscopy surgeries, etc.

Table of Contents

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. GLOBAL ARTHROSCOPY INSTRUMENTS MARKET: EVOLUTION & TRANSITION
  • 2.2. MARKET DEFINITION & SCOPE
  • 2.3. INDUSTRY STRUCTURE
  • 2.4. REGULATORY FRAMEWORK
  • 2.5. TOTAL MARKET ANALYSIS
    • 2.5.1. TOP 5 FINDINGS
    • 2.5.2. TOP 5 OPPORTUNITY MARKETS
    • 2.5.3. TOP 5 COMPANIES
    • 2.5.4. TOP 3 COMPETITIVE STRATEGIES
  • 2.6. ESTIMATION ANALYSIS
  • 2.7. STRATEGIC ANALYSIS
    • 2.7.1. INVESTMENT VS. ADOPTION MODEL
    • 2.7.2. 360-DEGREE INDUSTRY ANALYSIS
    • 2.7.3. PORTERS 5 FORCE MODEL
    • 2.7.4. SEE-SAW ANALYSIS
    • 2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
  • 2.8. COMPETITIVE ANALYSIS
    • 2.8.1. KEY STRATEGIES & ANALYSIS
    • 2.8.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
  • 2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
    • 2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
    • 2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
    • 2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. ONGOING TECHNOLOGICAL ADVANCEMENTS
    • 3.1.2. RISING GERIATRIC POPULATION
    • 3.1.3. HIGH INCIDENCE OF SPORTS RELATED INJURIES
    • 3.1.4. HIGH PREVALENCE OF MUSCULOSKELETAL DISORDERS
  • 3.2. EFFICIENT REIMBURSEMENT SYSTEM IN DEVELOPED COUNTRIESMARKET RESTRAINTS
    • 3.2.1. HIGH COST INVESTMENT ON ARTHROSCOPY INSTRUMENTS
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. EXPANSION & MODERNIZATION OF HEALTHCARE INFRASTRUCTURE ACROSS EMERGING COUNTRIES
    • 3.3.2. RISING INCLINATION OF PATIENTS AND HOSPITALS TOWARDS MINIMALLY INVASIVE SURGERIES
  • 3.4. MARKET CHALLENGES
    • 3.4.1. LACK OF TRAINED PERSONNEL

4. GLOBAL ARTHROSCOPY INSTRUMENTS MARKET BY PRODUCT

  • 4.1. MARKET DEFINITION AND SCOPE
  • 4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. MARKET SEGMENTATION
    • 4.5.1. GLOBAL ARTHROSCOPE MARKET
      • 4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
      • 4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
      • 4.5.1.3. KEY CONCLUSIONS
    • 4.5.2. GLOBAL ARTHROSCOPY IMPLANTS MARKET
      • 4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
      • 4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
      • 4.5.2.3. KEY CONCLUSIONS
    • 4.5.3. GLOBAL FLUID MANAGEMENT SYSTEMS MARKET
      • 4.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
      • 4.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
      • 4.5.3.3. KEY CONCLUSIONS
    • 4.5.4. GLOBAL MOTORIZED SHAVERS MARKET
      • 4.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
      • 4.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
      • 4.5.4.3. KEY CONCLUSIONS
    • 4.5.5. GLOBAL RF ABLATION SYSTEMS MARKET
      • 4.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
      • 4.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
      • 4.5.5.3. KEY CONCLUSIONS
    • 4.5.6. GLOBAL VISUALIZATION SYSTEMS MARKET
      • 4.5.6.1. ADOPTION SCENARIO & MARKET DETERMINANTS
      • 4.5.6.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
      • 4.5.6.3. KEY CONCLUSIONS

5. GLOBAL ARTHROSCOPY INSTRUMENTS MARKET BY APPLICATION

  • 5.1. MARKET DEFINITION AND SCOPE
  • 5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 5.4. OPPORTUNITY MATRIX
  • 5.5. MARKET SEGMENTATION
    • 5.5.1. GLOBAL KNEE ARTHROSCOPY MARKET
      • 5.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
      • 5.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
      • 5.5.1.3. KEY CONCLUSIONS
    • 5.5.2. GLOBAL SHOULDER ARTHROSCOPY MARKET
      • 5.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
      • 5.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
      • 5.5.2.3. KEY CONCLUSIONS
    • 5.5.3. GLOBAL OTHER ARTHROSCOPY APPLICATIONS MARKET
      • 5.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
      • 5.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
      • 5.5.3.3. KEY CONCLUSIONS

6. GLOBAL ARTHROSCOPY INSTRUMENTS MARKET BY END USER

  • 6.1. MARKET DEFINITION AND SCOPE
  • 6.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 6.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 6.4. OPPORTUNITY MATRIX
  • 6.5. MARKET SEGMENTATION
    • 6.5.1. GLOBAL AMBULATORY SURGICAL CENTERS & CLINICS MARKET
      • 6.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
      • 6.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
      • 6.5.1.3. KEY CONCLUSIONS
    • 6.5.2. GLOBAL HOSPITALS MARKET
      • 6.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
      • 6.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
      • 6.5.2.3. KEY CONCLUSIONS

7. COMPETITIVE LANDSCAPE

  • 7.1. KEY STRATEGIES
    • 7.1.1. LIST OF MERGERS AND ACQUISITION
    • 7.1.2. LIST OF JOINT VENTURES
    • 7.1.3. LIST OF PRODUCT LAUNCHES
    • 7.1.4. LIST OF PARTNERSHIPS

8. GEOGRAPHIC ANALYSIS

  • 8.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 8.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 8.3. OPPORTUNITY MATRIX
  • 8.4. GLOBAL ARTHROSCOPY INSTRUMENTS MARKET BY REGION 2015-2024
    • 8.4.1. NORTH AMERICA
      • 8.4.1.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
      • 8.4.1.2. TOP COUNTRY ANALYSIS
        • 8.4.1.2.1. U.S.
          • 8.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
          • 8.4.1.2.1.2. KEY CONCLUSIONS
        • 8.4.1.2.2. CANADA
          • 8.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
          • 8.4.1.2.2.2. KEY CONCLUSIONS
    • 8.4.2. EUROPE
      • 8.4.2.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
      • 8.4.2.2. TOP COUNTRY ANALYSIS
        • 8.4.2.2.1. UK
          • 8.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
          • 8.4.2.2.1.2. KEY CONCLUSIONS
        • 8.4.2.2.2. FRANCE
          • 8.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
          • 8.4.2.2.2.2. KEY CONCLUSIONS
        • 8.4.2.2.3. GERMANY
          • 8.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
          • 8.4.2.2.3.2. KEY CONCLUSIONS
        • 8.4.2.2.4. SPAIN
          • 8.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
          • 8.4.2.2.4.2. KEY CONCLUSIONS
        • 8.4.2.2.5. REST OF EUROPE
          • 8.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
          • 8.4.2.2.5.2. KEY CONCLUSIONS
    • 8.4.3. ASIA PACIFIC
      • 8.4.3.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
      • 8.4.3.2. TOP COUNTRY ANALYSIS
        • 8.4.3.2.1. CHINA
          • 8.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
          • 8.4.3.2.1.2. KEY CONCLUSIONS
        • 8.4.3.2.2. INDIA
          • 8.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
          • 8.4.3.2.2.2. KEY CONCLUSIONS
        • 8.4.3.2.3. JAPAN
          • 8.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
          • 8.4.3.2.3.2. KEY CONCLUSIONS
        • 8.4.3.2.4. AUSTRALIA
          • 8.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
          • 8.4.3.2.4.2. KEY CONCLUSIONS
        • 8.4.3.2.5. REST OF ASIA PACIFIC
          • 8.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
          • 8.4.3.2.5.2. KEY CONCLUSIONS
    • 8.4.4. ROW
      • 8.4.4.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
      • 8.4.4.2. TOP COUNTRY ANALYSIS
        • 8.4.4.2.1. LATIN AMERICA
          • 8.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
          • 8.4.4.2.1.2. KEY CONCLUSIONS
        • 8.4.4.2.2. MIDDLE EAST & AFRICA
          • 8.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
          • 8.4.4.2.2.2. KEY CONCLUSIONS

9. COMPANY PROFILES

  • 9.1. ARTHREX (U.S.)
    • 9.1.1. OVERVIEW
    • 9.1.2. PRODUCT PORTFOLIO
    • 9.1.3. STRATEGIC INITIATIVES
    • 9.1.4. SCOT ANALYSIS
    • 9.1.5. STRATEGIC ANALYSIS
  • 9.2. B. BRAUN MELSUNGEN AG (GERMANY)
    • 9.2.1. OVERVIEW
    • 9.2.2. PRODUCT PORTFOLIO
    • 9.2.3. STRATEGIC INITIATIVES
    • 9.2.4. SCOT ANALYSIS
    • 9.2.5. STRATEGIC ANALYSIS
  • 9.3. CONMED (U.S.)
    • 9.3.1. OVERVIEW
    • 9.3.2. PRODUCT PORTFOLIO
    • 9.3.3. STRATEGIC INITIATIVES
    • 9.3.4. SCOT ANALYSIS
    • 9.3.5. STRATEGIC ANALYSIS
  • 9.4. DEPUY SYNTHES COMPANIES (U.S.)
    • 9.4.1. OVERVIEW
    • 9.4.2. PRODUCT PORTFOLIO
    • 9.4.3. STRATEGIC INITIATIVES
    • 9.4.4. SCOT ANALYSIS
    • 9.4.5. STRATEGIC ANALYSIS
  • 9.5. GPC MEDICAL (INDIA)
    • 9.5.1. OVERVIEW
    • 9.5.2. PRODUCT PORTFOLIO
    • 9.5.3. STRATEGIC INITIATIVES
    • 9.5.4. SCOT ANALYSIS
    • 9.5.5. STRATEGIC ANALYSIS
  • 9.6. KARL STORZ (GERMANY)
    • 9.6.1. OVERVIEW
    • 9.6.2. PRODUCT PORTFOLIO
    • 9.6.3. STRATEGIC INITIATIVES
    • 9.6.4. SCOT ANALYSIS
    • 9.6.5. STRATEGIC ANALYSIS
  • 9.7. MEDICON (GERMANY)
    • 9.7.1. OVERVIEW
    • 9.7.2. PRODUCT PORTFOLIO
    • 9.7.3. STRATEGIC INITIATIVES
    • 9.7.4. SCOT ANALYSIS
    • 9.7.5. STRATEGIC ANALYSIS
  • 9.8. MEDTRONIC (U.S.)
    • 9.8.1. OVERVIEW
    • 9.8.2. PRODUCT PORTFOLIO
    • 9.8.3. STRATEGIC INITIATIVES
    • 9.8.4. SCOT ANALYSIS
    • 9.8.5. STRATEGIC ANALYSIS
  • 9.9. OLYMPUS (JAPAN)
    • 9.9.1. OVERVIEW
    • 9.9.2. PRODUCT PORTFOLIO
    • 9.9.3. STRATEGIC INITIATIVES
    • 9.9.4. SCOT ANALYSIS
    • 9.9.5. STRATEGIC ANALYSIS
  • 9.10. RICHARD WOLF GMBH (GERMANY)
    • 9.10.1. OVERVIEW
    • 9.10.2. PRODUCT PORTFOLIO
    • 9.10.3. STRATEGIC INITIATIVES
    • 9.10.4. SCOT ANALYSIS
    • 9.10.5. STRATEGIC ANALYSIS
  • 9.11. SKLAR (U.S.)
    • 9.11.1. OVERVIEW
    • 9.11.2. PRODUCT PORTFOLIO
    • 9.11.3. STRATEGIC INITIATIVES
    • 9.11.4. SCOT ANALYSIS
    • 9.11.5. STRATEGIC ANALYSIS
  • 9.12. SMITH & NEPHEW (U.K.)
    • 9.12.1. OVERVIEW
    • 9.12.2. PRODUCT PORTFOLIO
    • 9.12.3. STRATEGIC INITIATIVES
    • 9.12.4. SCOT ANALYSIS
    • 9.12.5. STRATEGIC ANALYSIS
  • 9.13. STRYKER CORPORATION (U.S.)
    • 9.13.1. OVERVIEW
    • 9.13.2. PRODUCT PORTFOLIO
    • 9.13.3. STRATEGIC INITIATIVES
    • 9.13.4. SCOT ANALYSIS
    • 9.13.5. STRATEGIC ANALYSIS
  • 9.14. SYMMETRY SURGICAL (U.S.)
    • 9.14.1. OVERVIEW
    • 9.14.2. PRODUCT PORTFOLIO
    • 9.14.3. STRATEGIC INITIATIVES
    • 9.14.4. SCOT ANALYSIS
    • 9.14.5. STRATEGIC ANALYSIS
  • 9.15. ZIMMER BIOMET (U.S.)
    • 9.15.1. OVERVIEW
    • 9.15.2. PRODUCT PORTFOLIO
    • 9.15.3. STRATEGIC INITIATIVES
    • 9.15.4. SCOT ANALYSIS
    • 9.15.5. STRATEGIC ANALYSIS
Back to Top